Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITK | Q08881 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.30 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26108388 | 1.00 | ITK (0.34) | ITKMEN1ALDH1A1GAAMAPT | |
| SCHEMBL26109881 | 0.87 | ROCK1 (0.37) | ITK | |
| SCHEMBL30629061 | 0.81 | ADRB2 (0.32) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL26108660 | 0.81 | ADRB2 (0.32) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL13344249 | 0.77 | ALPL (0.33) | ITKMEN1MAPTHPGDKMT2A | |
| SCHEMBL30587797 | 0.77 | MEN1 (0.36) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL26108216 | 0.77 | MEN1 (0.36) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL30629157 | 0.76 | RIPK1 (0.32) | ITK | |
| SCHEMBL30629044 | 0.72 | MAPT (0.38) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL26109423 | 0.72 | MAPT (0.38) | MEN1ALDH1A1GAAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836157-A | Oxadiazole derivative and preparation method and application thereof | 星希尔生物科技(上海)有限公司 | 2023-10-03 | — | — | CN | disclosed |